POMGNT1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: Unlike our findings, some reported patients with POMGNT1-CMD who had a reduced expression level of core α-DG; they had a normal expression level of laminin-α2, while other cases of dystroglycanopathies showed a relatively reduced leves of laminin-α2 [15].